Taken together, these results favored the notion that GRP30 activation inhibited MMP-9 expression via ERK1/2 signaling to at least partially preserve cardiac function and inhibited myocardial fibrosis in aged female hypertrophied hearts. This evidence concerns the gene MAPK3 and Myocardial fibrosis.